However, under different conditions oligoclonal expansion of CD8+ effector cells in the Eμ-TCL1 mouse model of CLL has been associated with disease control, whereas conversely, ablation of CD4+ T cells did not affect disease progression (33). The gene discussed is CD4; the disease is B-cell chronic lymphocytic leukemia.